Similarly, decreased levels of monocytes and proinflammatory factors (IL-6, CRP, and tumor necrosis factor-alpha [TNF-a]) are associated with poorer clinical outcomes in BD (Karthikeyan et al., 2022) and MDD (Moriarity et al., 2020). This evidence concerns the gene CRP and major depressive disorder.